 |
Dendritic cell/tumor cell fusion vaccine + recombinant human interleukin 12 |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-25 00:00:00 |
| Sponsor | CyTIX Inc.;7F Terada Bldg, 2-3-3 Shibakoen;Minato-ku |
Related Access Program